Search Results - "Dammag, Enas"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Bilateral Sudden Irreversible Hearing Loss in a Case of Chronic Myeloid Leukaemia: A Case Report by Malhan, Hafiz, Dammag, Enas, Alkahiry, Waiel, Ali, Gadallah, Bahkali, Fahad, Alhakim, Anas, Bakkar, Mohammad

    “…Chronic myeloid leukemia is a type of blood cancer that affects the bone marrow and results in an overproduction of immature WBCs. The genetic mutation that…”
    Get full text
    Journal Article
  2. 2

    Toll-like receptor 9 negatively related to clinical outcome of AML patients by Al-Kahiry, Waiel M A, Dammag, Enas A M, Abdelsalam, Hadeel S T, Fadlallah, Hayat K, Owais, Mona S

    “…Acute myeloid leukemia (AML) can modulate toll-like receptor-9 (TLR9) expression and activation. This study was conducted to elucidate the expression of TLR9…”
    Get full text
    Journal Article
  3. 3

    Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma by Alfaifi, Abdullah, Refai, Mohammed Y, Alsaadi, Mohammed, Bahashwan, Salem, Malhan, Hafiz, Al-Kahiry, Waiel, Dammag, Enas, Ageel, Ageel, Mahzary, Amjed, Albiheyri, Raed, Almehdar, Hussein, Qadri, Ishtiaq

    Published in Diagnostics (Basel) (23-02-2023)
    “…A wide range of histological as well as clinical properties are exhibited by B-cell non-Hodgkin's lymphomas. These properties could make the diagnostics…”
    Get full text
    Journal Article
  4. 4

    The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia by Hamed, Nahla A, Elhalawani, Nabil A, Kassem, Heba S, Ayad, Mona W, Dammag, Enas A

    “…Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm where pathogenesis is based on the oncoprotein termed BCR-ABL1.1 TET2 initiates DNA…”
    Get full text
    Journal Article
  5. 5

    TET2 Single Nucleotide Polymorphism in Myeloid Neoplasms Among Egyptian Patients by Dammag, Enas A., Hamed, Nahla A. M., Elhalawani, Nabil A., Kassem, Heba S., Ayad, Mona W.

    “…Acute myelogenous leukemia (AML) is a heterogeneous disease characterized by myeloid progenitor cells uncontrolled proliferation gradually replacing normal…”
    Get full text
    Journal Article
  6. 6
  7. 7